Item 26 of 674 (back to results) previous next   cholesteryl sulfate C007045               MeSH Unique Identifier: C007045 Scope Notes: Component of human seminal plasma & spermatozoa Chemical – Gene Interaction Note 1: Cholesteryl sulfate results in decreased expression of CYP11A1 mRNA Note 2: Cholesteryl sulfate results in decreased expression of STAR mRNA Click here for more information

Current search: C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities: Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] > Congenital Abnormalities [MESH:D000013] > Urogenital Abnormalities [MESH:D014564] > Disorders of Sex Development [MESH:D012734] > Adrenogenital Syndrome [MESH:D047808] > Adrenal Hyperplasia, Congenital [MESH:D000312] × Select any link to see items in a related category. more general categories    information about this item 1. Human Genes  1. Human Genes  Cytochrome P450s [HGNC:CYP] (1673)   cytochrome P450, family 11, subfamily A, polypeptide 01 [HGNC:CYP11A1] (65)  StAR-related lipid transfer (START) domain containing [HGNC:STARD] (91)   steroidogenic acute regulatory protein [HGNC:STAR] (57) 2. Interaction: Human Genes and Chemicals  2. Interaction: Human Genes and Chemicals  Decreases (5154)   expression (2187) 4. Semantic Terms  4. Semantic Terms  Entity [STY:T071] (48056)   Physical Object [STY:T072] (47583)   Substance [STY:T167] (46174)   Chemical [STY:T103] (46110)   Chemical Viewed Functionally [STY:T120] (28747)   Indicator, Reagent, or Diagnostic Aid [STY:T130] (903)  Pharmacologic Substance [STY:T121] (11019)  Chemical Viewed Structurally [STY:T104] (44741)   Organic Chemical [STY:T109] (44144)   Lipid [STY:T119] (2270)   Steroid [STY:T110] (1235) C04. Neoplasms  C04. Neoplasms  Neoplasms [MESH:D009369] (10293)   Cysts [MESH:D003560] (2625)   Ovarian Cysts [MESH:D010048] (2534)   Polycystic Ovary Syndrome [MESH:D011085] (2186) C10. Nervous System Diseases  C10. Nervous System Diseases  Nervous System Diseases [MESH:D009422] (13325)   Central Nervous System Diseases [MESH:D002493] (9745)   Brain Diseases [MESH:D001927] (9294)   Epilepsy [MESH:D004827] (6274)   Seizures [MESH:D012640] (4502)  Neurologic Manifestations [MESH:D009461] (8964)   Seizures [MESH:D012640] (4514) C12. Male Urogenital Diseases  C12. Male Urogenital Diseases  Male Urogenital Diseases [MESH:D052801] (8891)   Urogenital Abnormalities [MESH:D014564] (2065)   Disorders of Sex Development [MESH:D012734] (1637)   46, XY Disorders of Sex Development [MESH:D058490] (1060)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Adrenogenital Syndrome [MESH:D047808] (715)   Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) C13. Female Urogenital Diseases and Pregnancy Complications  C13. Female Urogenital Diseases and Pregnancy Complications  Female Urogenital Diseases [MESH:D052776] (8724)   Genital Diseases, Female [MESH:D005831] (5563)   Adnexal Diseases [MESH:D000291] (4273)   Ovarian Diseases [MESH:D010049] (4255)   Ovarian Cysts [MESH:D010048] (2534)   Polycystic Ovary Syndrome [MESH:D011085] (2186)  Urogenital Abnormalities [MESH:D014564] (2043)   Disorders of Sex Development [MESH:D012734] (1637)   46, XY Disorders of Sex Development [MESH:D058490] (1060)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Adrenogenital Syndrome [MESH:D047808] (715)   Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities  C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities  Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] (12152)   Congenital Abnormalities [MESH:D000013] (8109)   Urogenital Abnormalities [MESH:D014564] (2064)   Disorders of Sex Development [MESH:D012734] (1637)   46, XY Disorders of Sex Development [MESH:D058490] (1060)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Adrenogenital Syndrome [MESH:D047808] (715)   Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Genetic Diseases, Inborn [MESH:D030342] (9766)   Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Metabolism, Inborn Errors [MESH:D008661] (6032)   Steroid Metabolism, Inborn Errors [MESH:D043202] (962)   Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) C18. Nutritional and Metabolic Diseases  C18. Nutritional and Metabolic Diseases  Metabolic Diseases [MESH:D008659] (9025)   Metabolism, Inborn Errors [MESH:D008661] (6028)   Steroid Metabolism, Inborn Errors [MESH:D043202] (962)   Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289) C19. Endocrine System Diseases  C19. Endocrine System Diseases  Endocrine System Diseases [MESH:D004700] (8062)   Adrenal Gland Diseases [MESH:D000307] (2397)   Adrenal Insufficiency [MESH:D000309] (1599)  Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Gonadal Disorders [MESH:D006058] (5088)   Disorders of Sex Development [MESH:D012734] (1637)   46, XY Disorders of Sex Development [MESH:D058490] (1060)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Adrenogenital Syndrome [MESH:D047808] (715)   Adrenal Hyperplasia, Congenital [MESH:D000312] (674)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)  Ovarian Diseases [MESH:D010049] (4253)   Ovarian Cysts [MESH:D010048] (2534)   Polycystic Ovary Syndrome [MESH:D011085] (2186) C23. Pathological Conditions, Signs and Symptoms  C23. Pathological Conditions, Signs and Symptoms  Signs and Symptoms [MESH:D012816] (10659)   Neurologic Manifestations [MESH:D009461] (8702)   Seizures [MESH:D012640] (4502) D04. Polycyclic Compounds  D04. Polycyclic Compounds  Polycyclic Compounds [MESH:D011083] (22048)   Steroids [MESH:D013256] (6272)   Cholestanes [MESH:D002776] (1898)   Cholestenes [MESH:D002782] (1330)   Cholesterol [MESH:D002784] (331)   Cholesterol Esters [MESH:D002788] (79)  Sterols [MESH:D013261] (1332)   Cholesterol [MESH:D002784] (363)   Cholesterol Esters [MESH:D002788] (79) D10. Lipids  D10. Lipids  Lipids [MESH:D008055] (8597)   Membrane Lipids [MESH:D008563] (2387)   Sterols [MESH:D013261] (936)   Cholesterol [MESH:D002784] (359)   Cholesterol Esters [MESH:D002788] (79) D27. Chemical Actions and Uses  D27. Chemical Actions and Uses  Pharmacologic Actions [MESH:D020228] (2566)   Molecular Mechanisms of Pharmacological Action [MESH:D045504] (1155)   Enzyme Inhibitors [MESH:D004791] (520)   Protease Inhibitors [MESH:D011480] (125)   Serine Proteinase Inhibitors [MESH:D015842] (30)  Physiological Effects of Drugs [MESH:D045505] (1186)   Protective Agents [MESH:D020011] (164)   Anticarcinogenic Agents [MESH:D016588] (20)  Therapeutic Uses [MESH:D045506] (1611)   Antineoplastic Agents [MESH:D000970] (319)   Anticarcinogenic Agents [MESH:D016588] (20)  Specialty Uses of Chemicals [MESH:D020313] (713)   Protective Agents [MESH:D020011] (151)   Anticarcinogenic Agents [MESH:D016588] (20) F. Psychiatry and Psychology  F. Psychiatry and Psychology  Mental Disorders [MESH:D001523] (2063)   Sexual and Gender Disorders [MESH:D019968] (624)   Disorders of Sex Development [MESH:D012734] (609)   46, XY Disorders of Sex Development [MESH:D058490] (388)   Lipoid congenital adrenal hyperplasia [MESH:C537027] (289)